Results 21 to 30 of about 16,252 (181)

Role of selenium in the pathophysiology of cardiorenal anaemia syndrome

ESC Heart Failure, Volume 12, Issue 2, Page 770-780, April 2025.
Abstract Chronic kidney disease (CKD) and cardiovascular disease (CVD) have multiple bidirectional mechanisms, and anaemia is one of the critical factors that are associated with the progression of the two disorders [referred to as cardiorenal anaemia syndrome (CRAS)].
Shigeyuki Arai, Minoru Yasukawa, Shigeru Shibata   +2 more
wiley   +1 more source

Erythropoietin resistance in end-stage renal disease patient with gastric antral vascular ectasia

Brazilian Journal of Nephrology, 2015
We observed a case of recombinant human erythropoietin resistance caused by Gastric Antral Vascular Ectasia in a 40-year-old female with ESRD on hemodialysis.
Desiree Ji Re Lee, Juliana Fragata, José Osmar Medina Pestana, Sergio Draibe, Maria Eugênia Canziani, Miguel Cendoroglo, Miguel Ângelo de Góes Jr.   +6 more
doaj   +3 more sources

Use of Recombinant Human Erythropoietin in Renal Anemia in Children

Bangabandhu Sheikh Mujib Medical University Journal, 2009
Erythropoietin is a hormone highly effective as like as natural erythropoietin to maintain target hemoglobin and hematocrit level in renal anemia. Its advantage over blood transfusion has been proved by improving the quality of life and decreasing ...
Habibur Rahman, Salma Jahan, Afroza Begum, Golam Muinuddin, MM Hossain   +4 more
doaj   +1 more source

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

ESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang, Umar Raza, Jia Song, Junyan Lu, Shun Yao, Xiaohong Liu, Wei Zhang, Shujuan Li   +7 more
wiley   +1 more source

SEARCH OF NEW PHARMACEUTICALS ON THE BASIS OF DARBEPOETIN IN THE TREATMENT OF ISCHEMIC STROKE (REVIEW OF LITERATURE) [PDF]

Research Results in Pharmacology, 2017
The article contains the analysis of medical and biological publications from the global database created by the National Centre for Biology Information (NCBI), an intramural biotechnological division of the US National Library of Medicine.
Konstantin Reznikov, Narine Gorbunova, Pavel Kolesnichenko, Alexey Tverskoy, Darya Kostina, Dariya Bashkatova, Vladislava Nikitina   +6 more
doaj   +3 more sources

Recombinant human erythropoietin in nephrology

Biomedicine & Pharmacotherapy, 1989
rEPO therapy provides a unique opportunity to correct anemia in end-stage renal failure patients. Complete correction of the anemia, although possible, has some obvious disadvantages over a partial correction with a target hemoglobin of 10-13 g/dl or a hematocrit of 30-35%, respectively.
W, Samtleben, P, Ivanovich, H J, Gurland
openaire   +2 more sources

Divergence Linked to Possible Ecological Speciation in Blind Mole Rats: Integration of Thermal Biology and Bite Force in the Upper Galilee Blind Mole Rat (Nannospalax galili)

Integrative Zoology, EarlyView.
Basalt‐dwelling blind mole rats maintain lower body temperatures, show greater post‐digging thermal increases, and dig more efficiently than those from rendzina soils. Although metabolic rates and bite force did not differ between populations, these thermal and physiological shifts align with the greater mechanical resistance and seasonal hypoxia of ...
Matěj Lövy, Jan Okrouhlík, František Vejmělka, Pavlína Schwarzová, Maja Rendulić, Eviatar Nevo, Radim Šumbera   +6 more
wiley   +1 more source

Darbepoietin-alfa has comparable erythropoietic stimulatory effects to recombinant erythropoietin whilst preserving the bone marrow microenvironment

Haematologica, 2013
Erythropoiesis stimulating agents are widely used for the treatment of anemia. Recently, we reported erythroid expansion with impaired B lymphopoiesis and loss of trabecular bone in C57BL/6 mice following ten days of treatment with low-dose short acting ...
Sita R. Dewamitta, Megan R. Russell, Harshal Nandurkar, Carl R. Walkley   +3 more
doaj   +1 more source

Influence of hemoglobin level and dose of administered recombinant human beta erythropoietin on survival of hemodialysis patients [PDF]

Vojnosanitetski Pregled, 2011
Background/Aim. In patients with end-stage renal disease, treatment with erythropoietin lowers cardiovascular morbidity, improves quality of life and patient survival.
Knežević Violeta, Milošević Aleksandra, Vodopivec Slavenka, Božić Dušan, Budošan Ivana, Majić Milena   +5 more
doaj   +1 more source

Guideline for Medication Management of Distressing Symptoms in Older Patients Receiving End‐of‐Life Palliative Care

Journal of Evidence-Based Medicine, EarlyView.
ABSTRACT Older patients receiving end‐of‐life palliative care often present with multiple geriatric syndromes, frailty, and comorbid symptom burden, resulting in a high risk of medication‐related harm. This guideline focuses on pharmacological management of distressing symptoms in older patients receiving end‐of‐life or hospice‐oriented palliative care,
Daiping Li, Yanwu Yang, Yan Zhang, Jirong Yue, Birong Dong, Meiling Ge, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University   +7 more
wiley   +1 more source